Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CDK inhibitors and their use as pharmaceuticals

CDK inhibitors and their use as pharmaceuticals

US Patent 12129262 · Granted Oct 29, 2024

Estimated economic value: $1,622,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CDK inhibitors and their use as pharmaceuticals2025
BRM targeting compounds and associated methods of use2025
Aminopyrazine derivatives as PI3K-γ inhibitors2025
Aminopyrazine derivatives as PI3K-γ inhibitors2025
Aminopyrazine diol compounds as PI3K-y inhibitors2025
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c] pyridin-7(6H)-ones as in2025
Heterocyclylamines as PI3K inhibitors2025
Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor2024
Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disord2024
Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors2024
Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors2024
Heterocyclic derivatives as PI3K inhibitors2024